We centralize our peptide production at the Eurogentec's US subsidiary “AnaSpec”

Eurogentec consolidates its peptide production activity. From April 1st 2021, custom peptides will be totally produced at AnaSpec (Eurogentec’s US subsidiary).

Eurogentec has been and remains an actor in the production of custom peptides.

Until now, we had 2 peptide production sites Eurogentec headquarters (BE, Europe) and our fully-owned subsidiary Anaspec (USA, America).

We strategically decided to concentrate our peptide production activities at Anaspec.

From April 1st, AnaSpec will become our single center of excellence for peptide manufacturing.

 

We remain at your side

Both business management and customer support are unchanged, hence Eurogentec remains the only contact point for our European customers.

You can still contact us, request a quote or order your custom peptides as usual by phone or by email.

 

Same guaranteed quality

Expertise harmonization guarantees that Eurogentec and AnaSpec are operating according to the same standards. We are still producing and delivering peptides with the same high-quality level.

In addition, our production and delivery schedules will be maintained.

 

Large choice of specifications

Have access to a variety of high-quality syntheses and exotic modifications.

  • Complex peptides
  • Bulk quantities
  • Peptides to be used as critical raw materials

Custom peptide overview

 

About AnaSpec

AnaSpec is a leading pioneer in peptide synthesis and is an expert in complex synthesis as peptides with multiple modifications or complex structures (cyclic, stapled peptides).

More About Anaspec

Media gallery

Related articles

Products & Services

More
img-en-annual-closing-news-event-01.jpg

Annual Closing

Eurogentec will be closed from Friday the 25th of December 2020 until Friday the 1st of January 2021.